Metabotropic GPCRs: TGR5 and P2Y Receptors in Health and Diseases 2018
DOI: 10.1007/978-981-13-1571-8_1
|View full text |Cite
|
Sign up to set email alerts
|

Overview of G-Protein Coupled Receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 81 publications
0
3
0
Order By: Relevance
“…Besides G-protein, GPCRs can also mediate signal through β-arrestins, multifunctional adaptor proteins that activate several signaling molecules such as c-Src, extracellular regulated kinase (ERK), Janus-activated kinase (JNK), and small GTPase RhoA by forming a complex with them. Some GPCR ligands activate either G-protein or β-arrestin; this event is called as “biased activation” …”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Besides G-protein, GPCRs can also mediate signal through β-arrestins, multifunctional adaptor proteins that activate several signaling molecules such as c-Src, extracellular regulated kinase (ERK), Janus-activated kinase (JNK), and small GTPase RhoA by forming a complex with them. Some GPCR ligands activate either G-protein or β-arrestin; this event is called as “biased activation” …”
mentioning
confidence: 99%
“…Some GPCR ligands activate either Gprotein or β-arrestin; this event is called as "biased activation". 2 Due to the key roles of GPCRs in cell physiology and homeostasis, altered signaling pathways associated with GPCRs are implicated in the pathophysiology of various diseases, including cancer, infections, and metabolic, immunological, or neurodegenerative disorders. Approximately 40% of clinically approved drugs mediate their effects by modulating GPCRs, which makes them attractive targets for drug screening and discovery.…”
mentioning
confidence: 99%
See 1 more Smart Citation